Dashboard
Manage Tickers

AKBA Akebia Therapeutics, Inc.

Nasdaq akebia.com


$ 2.20 $ 0.11 (5.24 %)    

Friday, 31-Oct-2025 19:27:15 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 2.21
$ 2.11
$ 2.11 x 41
$ 2.23 x 100
$ 2.07 - $ 2.23
$ 1.52 - $ 4.08
6,112,330
na
585.97M
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-28-2023 06-30-2023 10-Q
10 05-08-2023 03-31-2023 10-Q
11 03-10-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 03-12-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-12-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 03-06-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-08-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 03-14-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-akebia-therapeutics-lowers-price-target-to-6
HC Wainwright & Co. Maintains Buy on Akebi...
10/30/2025 11:51:16

HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and lowers the price...

fda-pushback-prompts-akebia-to-drop-broad-label-pursuit-for-kidney-disease-drug
FDA Pushback Prompts Akebia To Drop Broad ...
10/29/2025 18:13:46

Akebia shares decline after the company ends plans for its VALOR trial, citing FDA feedback and high costs tied to expanding Va...

btig-maintains-buy-on-akebia-therapeutics-lowers-price-target-to-5
BTIG Maintains Buy on Akebia Therapeutics,...
10/29/2025 17:49:36

BTIG analyst Julian Harrison maintains Akebia Therapeutics (NASDAQ:AKBA) with a Buy and lowers the price target from $10 to $5.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 17:06:03

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 12:06:08

mondelez-international-stride-varonis-systems-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Mondelez International, Stride, Varonis Sy...
10/29/2025 12:05:16

why-teradyne-shares-are-trading-higher-by-more-than-20-here-are-20-stocks-moving-premarket
Why Teradyne Shares Are Trading Higher By ...
10/29/2025 09:05:41

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/28/2025 21:13:44

akebia-therapeutics-says-fda-has-not-come-to-alignment-on-path-forward-for-design-of-valor-clinical-trial-for-use-of-vafseo-in-non-dialysis-patients
Akebia Therapeutics Says FDA Has Not Come ...
10/28/2025 20:34:48

akebia-therapeutics-and-innovative-renal-care-announce--vafseo-availability-in-irc-dialysis-clinics
Akebia Therapeutics And Innovative Renal C...
08/21/2025 12:10:09

akebia-therapeutics-q2-sales-62472m-beat-47637m-estimate
Akebia Therapeutics Q2 Sales $62.472M Beat...
08/07/2025 11:03:41

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $62.472 million which beat the analyst consensus estimate of $47....

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

earnings-preview-for-akebia-therapeutics
Earnings Preview For Akebia Therapeutics
08/06/2025 19:03:28

akebia-therapeutics-initiates-post-marketing-study-to-identify-additional-potential-benefits-of-vafseo
Akebia Therapeutics Initiates Post-Marketi...
08/04/2025 12:09:08

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

Core News & Articles
9 Health Care Stocks Whale Activity In Tod...
06/04/2025 17:35:27

akebia-therapeutics-announces-publication-in-jasn-of-us-and-non-us-subgroup-analyses-from-vadadustat-global-phase-3-trials-showing-comparable-safety-and-efficacy-in-dialysis-dependent-ckd-patients-and-highlighting-elevated-mace-risk-in-us-nondialysis-dependent-ckd-patients
Akebia Therapeutics Announces Publication ...
06/04/2025 12:19:56

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

hc-wainwright--co-assumes-akebia-therapeutics-at-buy-announces-price-target-of-8
HC Wainwright & Co. Assumes Akebia Therape...
06/04/2025 11:20:49

HC Wainwright & Co. analyst Matthew Caufield assumes Akebia Therapeutics (NASDAQ:AKBA) with a Buy rating and announces P...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/08/2025 12:07:05

akebia-therapeutics-q1-eps-003-beats-004-estimate-sales-5734m-beat-4488m-estimate
Akebia Therapeutics Q1 EPS $0.03 Beats $(0...
05/08/2025 11:06:00

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION